3PC-021 Formulation of voriconazole ovules and efficacy in vulvovaginal Ccandidiasis by candida glabrata: a case report

• Published in: European journal of hospital pharmacy. Science and practice Vol. 31; no. Suppl 1; p. A38
• Main Authors: López Gómez, A, Rodríguez-De Francisco, L, Carrascal-Mozo, C, Lora-Escobar, SJ, Suárez Casillas, P, Hevia-Álvarez, E, Quintero-García, JP, Rodríguez-Hernández, MJ
• Format: Journal Article
• Language: English
• Published: London British Medical Journal Publishing Group 20.03.2024; BMJ Publishing Group LTD
• Subjects: Conflicts of interest; Polyethylene glycol; Section 3: Production and compounding; Vagina

Background and Importance Candida glabrata is a vaginal coloniser causing vulvovaginal candidiasis (VVC), usually asymptomatic. Typical first-line therapies, boric acid or nystatin ovules, are not effective due to their inherent resistance. Flucytosine, amphotericin B or voriconazole would be the tr...